Eurelings LEM, Missotten TOAR, van Velthoven MEJ, van DaeLe PLA, et al. Long-term follow-up of patients with uveitis treated with adalimumab: response rates and reasons for discontinuation of therapy. Am J Ophthalmol 2022 Mar 18. pii: S0002-9394(22)00108.
PMID: 35314190